• Product nameAnti-ABCC9 antibody
    See all ABCC9 primary antibodies
  • Description
    Rabbit polyclonal to ABCC9
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Rabbit, Goat, Horse, Chicken, Guinea pig, Cow, Cat, Dog, Pig, Caenorhabditis elegans, Drosophila melanogaster, Zebrafish
  • Immunogen

    Synthetic peptide designed within residues: AVVTEGGENF SVGQRQLFCL ARAFVRKSSI LIMDEATASI DMATENILQK, corresponding to internal sequence amino acids 1440 - 1489 of Human ABCC9 (NP_005682)

  • Positive control
    • 721_B cell lysate.



Our Abpromise guarantee covers the use of ab84299 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 174 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.


  • FunctionSubunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with KCNJ11. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation.
  • Involvement in diseaseDefects in ABCC9 are the cause of cardiomyopathy dilated type 1O (CMD1O) [MIM:608569]; also known as dilated cardiomyopathy with ventricular tachycardia. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
    Defects in ABCC9 are the cause of familial atrial fibrillation type 12 (ATFB12) [MIM:614050]. ATFB12 is a familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure.
  • Sequence similaritiesBelongs to the ABC transporter superfamily. ABCC family. Conjugate transporter (TC 3.A.1.208) subfamily.
    Contains 2 ABC transmembrane type-1 domains.
    Contains 2 ABC transporter domains.
  • Cellular localizationMembrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • ABC37 antibody
    • abcC9 antibody
    • ABCC9_HUMAN antibody
    • AI414027 antibody
    • AI449286 antibody
    • ATFB12 antibody
    • ATP-binding cassette sub-family C member 9 antibody
    • ATP-binding cassette transporter sub-family C member 9 antibody
    • ATP-binding cassette, sub-family C (CFTR/MRP), member 9 antibody
    • CANTU antibody
    • CMD1O antibody
    • FLJ36852 antibody
    • Sulfonylurea receptor 2 antibody
    • Sulfonylurea-binding protein 2 antibody
    • SUR2 antibody
    • SUR2A antibody
    • SUR2B antibody
    see all

Anti-ABCC9 antibody images

  • Predicted band size : 174 kDa
    Western blot analysis of 10µg SUR1 KO (lane 1) 10µg WT (lane 2) 0.1µg SUR1 overexpressing (lane 3) mouse ventricle lysates and 10µg cannine ventricle lysate (lane 4) labeling ABCC9 with ab84299 at 1:1000. A HRP-conjugated anti-rabbit (1:2000) was used as the secondary antibody.
  • Anti-ABCC9 antibody (ab84299) at 1 µg/ml + 721_B cell lysate at 10 µg

    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 174 kDa
    Observed band size : 174 kDa
    Additional bands at : 45 kDa,70 kDa. We are unsure as to the identity of these extra bands.

References for Anti-ABCC9 antibody (ab84299)

ab84299 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab84299.
Please use the links above to contact us or submit feedback about this product.